Clinical Trial Update: A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial updating on the interaction between SPD503 and Vyvanse when administered alone and in combination in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• SPD503
• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: Shire | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2010-08-02